The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

Background & Aims: NAFLD is a growing health concern. The aim of the Fatty Liver Assessment in Germany (FLAG) study was to assess disease burden and provide data on the standard of care from secondary care. Methods: The FLAG study is an observational real-world study in patients with NAFLD e...

Full description

Bibliographic Details
Main Authors:	Wolf Peter Hofmann, Peter Buggisch, Lisa Schubert, Nektarios Dikopoulos, Jeannette Schwenzer, Marion Muche, Gisela Felten, Renate Heyne, Patrick Ingiliz, Anna Schmidt, Kerstin Stein, Heiner Wedemeyer, Thomas Berg, Johannes Wiegand, Frank Lammert, Stefan Zeuzem, Jörn M. Schattenberg
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	JHEP Reports
Subjects:	NASH NAFLD Real world Metabolic syndrome Liver fibrosis Co-morbidities
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555920301026

Similar Items

Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01)

Dual Role of MicroRNAs in NAFLD
by: Valerio Nobili, et al.
Published: (2013-04-01)

Microbiota, Fiber, and NAFLD: Is There Any Connection?
by: Alejandra Pérez-Montes de Oca, et al.
Published: (2020-10-01)

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
by: Umair Iqbal, et al.
Published: (2018-09-01)

The use of CHS-131, a selective PPAR-gamma modulator to treat NAFLD/NASH
by: Joshi, Aditya
Published: (2020)

Non-alcoholic fatty liver disease (NAFLD) – epidemic of the XXI century
by: Dominika Maciejewska, et al.
Published: (2018-07-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD
by: Rosann Cholankeril, et al.
Published: (2018-10-01)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
by: Małgorzata Moszak, et al.
Published: (2021-02-01)

EZH2 as a Potential Target for NAFLD Therapy
by: Hyun Jung Lim, et al.
Published: (2020-11-01)

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
by: Eveline Bruinstroop, et al.
Published: (2021-11-01)

The association of adiponectin gene polymorphisms with susceptibility and progression of NAFLD in a cohort of Egyptian patients
by: Eman M. Hasan, et al.
Published: (2021-05-01)

Hepatitis B and NAFLD: Lives Crossed
by: María Luisa Morales,, et al.
Published: (2017-03-01)

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01)

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
by: Douglas G. Mashek
Published: (2021-08-01)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
by: Miriam Longo, et al.
Published: (2021-04-01)

Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review
by: Lydie Carreres, et al.
Published: (2021-04-01)

Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
by: Stefano Bellentani, et al.
Published: (2009-01-01)

Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk
by: Siarhei A. Dabravolski, et al.
Published: (2021-04-01)

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
by: Brian Finan, et al.
Published: (2021-04-01)

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
by: Myriam Alexander, et al.
Published: (2019-05-01)

Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats
by: Ali Amirinejad, et al.
Published: (2021-09-01)

Imaging biomarkers of NAFLD, NASH, and fibrosis
by: Veeral Ajmera, et al.
Published: (2021-08-01)

Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
by: Dominika Maciejewska, et al.
Published: (2020-04-01)

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
by: Amélio F. Godoy-Matos, et al.
Published: (2020-07-01)

Insights into the Role of PPARβ/δ in NAFLD
by: Jiapeng Chen, et al.
Published: (2018-06-01)

When to Initiate Weight Loss Medications in the NAFLD Population
by: Eric R. Yoo, et al.
Published: (2018-09-01)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
by: Anna Michelotti, et al.
Published: (2021-08-01)

The Role of Vitamin E in the Treatment of NAFLD
by: Brandon J. Perumpail, et al.
Published: (2018-09-01)

New insight and potential therapy for NAFLD: CYP2E1 and flavonoids
by: Kaiyue Wang, et al.
Published: (2021-05-01)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
by: Jörn M. Schattenberg, et al.
Published: (2019-07-01)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
by: Brandon J. Perumpail, et al.
Published: (2019-02-01)

Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study
by: Reda Albadawy, et al.
Published: (2021-09-01)

Mitochondrial oxidative function in NAFLD: Friend or foe?
by: Michael Shum, et al.
Published: (2021-08-01)

Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
by: Pau Vancells Lujan, et al.
Published: (2021-04-01)

The Importance of the Fatty Acid Transporter L-carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Dragana Savic, et al.
Published: (2020-07-01)

Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
by: Aybike Birerdinc, et al.
Published: (2018-01-01)

Treatment regimens for non-alcoholic fatty liver disease
by: Brian P. Lam, et al.
Published: (2009-01-01)

NAFLD in the Elderly
by: Alqahtani SA, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_qte19ing3140mem5bkvbqiph44